AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2017
Sep 6, 2017
30016_dirs_2017-09-06_00198954-f86f-4548-9039-994390db0b07.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2017-09-01
Reporting Person: Studer Jacqueline (CVP, Gen. Counsel & Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-09-01 | Common Stock | M | 1129 | — | Acquired | 4704 | Direct |
| 2017-09-01 | Common Stock | F | 365 | $154.98 | Disposed | 4339 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-09-01 | Restricted Stock Unit | $ | M | 1129 | Disposed | Common Stock (1129) | Direct |
Footnotes
F1: Includes a total of 79 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2017 and June 30, 2017.
F2: These restricted stock units were granted to the reporting person on September 1, 2014. Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock and vest in five equal annual installments, beginning on the first anniversary date of the date of grant. The number of restricted stock units reported was adjusted to reflect a 2-for-1 stock split in the form of a 100% stock dividend on IDEXX Laboratories, Inc. common stock paid on June 15, 2015.
F3: Not applicable.